Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema
Background. Pseudotumor cerebri is an acknowledged but unusual complication of oral minocycline use. Vision loss and papilledema have been described as mild and transient, and some authors suggest that treatment is not needed. Methods. Case series of 2 patients with severe papilledema and visual fie...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2009-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2009/203583 |
| id |
doaj-e59f9abb07534b09aa41d594b8790f93 |
|---|---|
| record_format |
Article |
| spelling |
doaj-e59f9abb07534b09aa41d594b8790f932020-11-24T20:40:22ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582009-01-01200910.1155/2009/203583203583Minocycline-Associated Pseudotumor Cerebri with Severe PapilledemaSimon R. Bababeygy0Michael X. Repka1Prem S. Subramanian2Department of Ophthalmology, The Johns Hopkins Hospitals, 600 N. Wolfe St, Baltimore, MD 21287, USADepartment of Ophthalmology, The Johns Hopkins Hospitals, 600 N. Wolfe St, Baltimore, MD 21287, USADepartment of Ophthalmology, The Johns Hopkins Hospitals, 600 N. Wolfe St, Baltimore, MD 21287, USABackground. Pseudotumor cerebri is an acknowledged but unusual complication of oral minocycline use. Vision loss and papilledema have been described as mild and transient, and some authors suggest that treatment is not needed. Methods. Case series of 2 patients with severe papilledema and visual field loss. Results. Severe pseudotumor cerebri developed in 2 nonobese patients taking minocycline. Their disease required further treatment even upon drug discontinuation because of visual field loss and papilledema. Conclusions. Minocycline-associated pseudotumor cerebri is not always a self-limited condition and may require aggressive medical or surgical management.http://dx.doi.org/10.1155/2009/203583 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Simon R. Bababeygy Michael X. Repka Prem S. Subramanian |
| spellingShingle |
Simon R. Bababeygy Michael X. Repka Prem S. Subramanian Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema Journal of Ophthalmology |
| author_facet |
Simon R. Bababeygy Michael X. Repka Prem S. Subramanian |
| author_sort |
Simon R. Bababeygy |
| title |
Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema |
| title_short |
Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema |
| title_full |
Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema |
| title_fullStr |
Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema |
| title_full_unstemmed |
Minocycline-Associated Pseudotumor Cerebri with Severe Papilledema |
| title_sort |
minocycline-associated pseudotumor cerebri with severe papilledema |
| publisher |
Hindawi Limited |
| series |
Journal of Ophthalmology |
| issn |
2090-004X 2090-0058 |
| publishDate |
2009-01-01 |
| description |
Background. Pseudotumor cerebri is an acknowledged but unusual complication of oral minocycline use. Vision loss and papilledema have been described as mild and transient, and some authors suggest that treatment is not needed.
Methods. Case series of 2 patients with severe papilledema and visual field loss. Results. Severe pseudotumor cerebri developed in 2 nonobese patients taking minocycline. Their disease required further treatment even upon drug discontinuation because of visual field loss and papilledema.
Conclusions. Minocycline-associated pseudotumor cerebri is not always a self-limited condition and may require aggressive medical or surgical management. |
| url |
http://dx.doi.org/10.1155/2009/203583 |
| work_keys_str_mv |
AT simonrbababeygy minocyclineassociatedpseudotumorcerebriwithseverepapilledema AT michaelxrepka minocyclineassociatedpseudotumorcerebriwithseverepapilledema AT premssubramanian minocyclineassociatedpseudotumorcerebriwithseverepapilledema |
| _version_ |
1716827156877672448 |